Arundathy N. Pandite - 10 Jan 2022 Form 4 Insider Report for Shattuck Labs, Inc. (STTK)

Role: Chief Medical Officer
Signature: /s/ Erin Ator Thomson, Attorney-in-fact for Arundathy N. Pandite
Issuer symbol: STTK
Transactions as of: 10 Jan 2022
Net transactions value: $0
Form type: 4
Filing time: 12 Jan 2022, 17:45:13 UTC
Previous filing: 18 Aug 2021
Next filing: 21 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	STTK	Common Stock	Award	$0	+34,738	+33%	$0.000000	140,904	10 Jan 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	STTK	Stock Option (Right to Buy)	Award	$0	+69,475		$0.000000	69,475	10 Jan 2022	Common Stock	69,475	$7.43	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of 34,738 restricted stock units, which will vest in four equal annual installments beginning on January 10, 2023, subject to the Reporting Person's continued service to the Issuer.
F2	This option represented a right to purchase a total of 69,475 shares of the Issuer's common stock, one quarter of which will vest on January 10, 2023, with the remaining three quarters vesting in equal monthly installments through January 10, 2026, subject to the Reporting Person's continued service to the Issuer.